<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32034402</PMID><DateCompleted><Year>2020</Year><Month>05</Month><Day>22</Day></DateCompleted><DateRevised><Year>2020</Year><Month>05</Month><Day>22</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1362-4962</ISSN><JournalIssue CitedMedium="Internet"><Volume>48</Volume><Issue>6</Issue><PubDate><Year>2020</Year><Month>Apr</Month><Day>06</Day></PubDate></JournalIssue><Title>Nucleic acids research</Title><ISOAbbreviation>Nucleic Acids Res</ISOAbbreviation></Journal><ArticleTitle>Structural basis of the zinc-induced cytoplasmic aggregation of the RNA-binding protein SFPQ.</ArticleTitle><Pagination><StartPage>3356</StartPage><EndPage>3365</EndPage><MedlinePgn>3356-3365</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/nar/gkaa076</ELocationID><Abstract><AbstractText>SFPQ is a ubiquitous nuclear RNA-binding protein implicated in many aspects of RNA biogenesis. Importantly, nuclear depletion and cytoplasmic accumulation of SFPQ has been linked to neuropathological conditions such as Alzheimer's disease (AD) and amyotrophic lateral sclerosis (ALS). Here, we describe a molecular mechanism by which SFPQ is mislocalized to the cytoplasm. We report an unexpected discovery of the infinite polymerization of SFPQ that is induced by zinc binding to the protein. The crystal structure of human SFPQ in complex with zinc at 1.94 &#xc5; resolution reveals intermolecular interactions between SFPQ molecules that are mediated by zinc. As anticipated from the crystal structure, the application of zinc to primary cortical neurons induced the cytoplasmic accumulation and aggregation of SFPQ. Mutagenesis of the three zinc-coordinating histidine residues resulted in a significant reduction in the zinc-binding affinity of SFPQ in solution and the zinc-induced cytoplasmic aggregation of SFPQ in cultured neurons. Taken together, we propose that dysregulation of zinc availability and/or localization in neuronal cells may represent a mechanism for the imbalance in the nucleocytoplasmic distribution of SFPQ, which is an emerging hallmark of neurodegenerative diseases including AD and ALS.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Victoria 3086, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ringuet</LastName><ForeName>Mitchell</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Clem Jones Centre for Ageing Dementia Research, Queensland Brain Institute, The University of Queensland, Brisbane, Queensland 4072, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Whitten</LastName><ForeName>Andrew E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Australian Nuclear Science and Technology Organisation (ANSTO), Lucas Heights, NSW 2234, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caria</LastName><ForeName>Sofia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Victoria 3086, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>SAXS/WAXS, Australian Synchrotron, ANSTO, Clayton, Victoria 3168, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Yee Wa</ForeName><Initials>YW</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Victoria 3086, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Badhan</LastName><ForeName>Rahul</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Victoria 3086, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anggono</LastName><ForeName>Victor</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Clem Jones Centre for Ageing Dementia Research, Queensland Brain Institute, The University of Queensland, Brisbane, Queensland 4072, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Mihwa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Victoria 3086, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nucleic Acids Res</MedlineTA><NlmUniqueID>0411011</NlmUniqueID><ISSNLinking>0305-1048</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000072670">PTB-Associated Splicing Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016601">RNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>63231-63-0</RegistryNumber><NameOfSubstance UI="D012313">RNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>J41CSQ7QDS</RegistryNumber><NameOfSubstance UI="D015032">Zinc</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002467" MajorTopicYN="N">Cell Nucleus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018360" MajorTopicYN="N">Crystallography, X-Ray</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003593" MajorTopicYN="N">Cytoplasm</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072670" MajorTopicYN="N">PTB-Associated Splicing Factor</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000648" MajorTopicYN="Y">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058105" MajorTopicYN="N">Polymerization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012313" MajorTopicYN="N">RNA</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016601" MajorTopicYN="N">RNA-Binding Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000648" MajorTopicYN="Y">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015032" MajorTopicYN="N">Zinc</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>1</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>1</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>11</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>5</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32034402</ArticleId><ArticleId IdType="pmc">PMC7102971</ArticleId><ArticleId IdType="doi">10.1093/nar/gkaa076</ArticleId><ArticleId IdType="pii">5730376</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nussbacher J.K., Tabet R., Yeo G.W., Lagier-Tourenne C.. Disruption of RNA metabolism in neurological diseases and emerging therapeutic interventions. Neuron. 2019; 102:294&#x2013;320.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6545120</ArticleId><ArticleId IdType="pubmed">30998900</ArticleId></ArticleIdList></Reference><Reference><Citation>Conlon E.G., Manley J.L.. RNA-binding proteins in neurodegeneration: mechanisms in aggregate. Genes Dev. 2017; 31:1509&#x2013;1528.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5630017</ArticleId><ArticleId IdType="pubmed">28912172</ArticleId></ArticleIdList></Reference><Reference><Citation>Maziuk B., Ballance H.I., Wolozin B.. Dysregulation of RNA binding protein aggregation in neurodegenerative disorders. Front Mol. Neurosci. 2017; 10:89.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5378767</ArticleId><ArticleId IdType="pubmed">28420962</ArticleId></ArticleIdList></Reference><Reference><Citation>Yarosh C.A., Iacona J.R., Lutz C.S., Lynch K.W.. PSF: nuclear busy-body or nuclear facilitator. Wiley Interdiscip. Rev. RNA. 2015; 6:351&#x2013;367.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4478221</ArticleId><ArticleId IdType="pubmed">25832716</ArticleId></ArticleIdList></Reference><Reference><Citation>Knott G.J., Bond C.S., Fox A.H.. The DBHS proteins SFPQ, NONO and PSPC1: a multipurpose molecular scaffold. Nucleic Acids Res. 2016; 44:3989&#x2013;4004.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4872119</ArticleId><ArticleId IdType="pubmed">27084935</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowery L.A., Rubin J., Sive H.. Whitesnake/sfpq is required for cell survival and neuronal development in the zebrafish. Dev. Dyn. 2007; 236:1347&#x2013;1357.</Citation><ArticleIdList><ArticleId IdType="pubmed">17393485</ArticleId></ArticleIdList></Reference><Reference><Citation>Cosker K.E., Fenstermacher S.J., Pazyra-Murphy M.F., Elliott H.L., Segal R.A.. The RNA-binding protein SFPQ orchestrates an RNA regulon to promote axon viability. Nat. Neurosci. 2016; 19:690&#x2013;696.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5505173</ArticleId><ArticleId IdType="pubmed">27019013</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeuchi A., Iida K., Tsubota T., Hosokawa M., Denawa M., Brown J.B., Ninomiya K., Ito M., Kimura H., Abe T. et al. .. Loss of sfpq causes long-gene transcriptopathy in the brain. Cell Rep. 2018; 23:1326&#x2013;1341.</Citation><ArticleIdList><ArticleId IdType="pubmed">29719248</ArticleId></ArticleIdList></Reference><Reference><Citation>Ke Y.D., Dramiga J., Schutz U., Kril J.J., Ittner L.M., Schroder H., Gotz J.. Tau-mediated nuclear depletion and cytoplasmic accumulation of SFPQ in Alzheimer's and Pick's disease. PLoS One. 2012; 7:e35678.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3338448</ArticleId><ArticleId IdType="pubmed">22558197</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J., Shu R., Zhu Y.. Dysregulation and dislocation of SFPQ disturbed DNA organization in alzheimer's disease and frontotemporal dementia. J. Alzheimers Dis. 2018; 61:1311&#x2013;1321.</Citation><ArticleIdList><ArticleId IdType="pubmed">29376859</ArticleId></ArticleIdList></Reference><Reference><Citation>Luisier R., Tyzack G.E., Hall C.E., Mitchell J.S., Devine H., Taha D.M., Malik B., Meyer I., Greensmith L., Newcombe J. et al. .. Intron retention and nuclear loss of SFPQ are molecular hallmarks of ALS. Nat. Commun. 2018; 9:2010.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5964114</ArticleId><ArticleId IdType="pubmed">29789581</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M., Sadowska A., Bekere I., Ho D., Gully B.S., Lu Y., Iyer K.S., Trewhella J., Fox A.H., Bond C.S.. The structure of human SFPQ reveals a coiled-coil mediated polymer essential for functional aggregation in gene regulation. Nucleic Acids Res. 2015; 43:3826&#x2013;3840.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4402515</ArticleId><ArticleId IdType="pubmed">25765647</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M., Passon D.M., Hennig S., Fox A.H., Bond C.S.. Construct optimization for studying protein complexes: obtaining diffraction-quality crystals of the pseudosymmetric PSPC1-NONO heterodimer. Acta Crystallogr. 2011; 67:981&#x2013;987.</Citation><ArticleIdList><ArticleId IdType="pubmed">22101825</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Q., Khorasanizadeh S., Miyoshi Y., Lazar M.A., Rastinejad F.. Structural elements of an orphan nuclear receptor-DNA complex. Mol. Cell. 1998; 1:849&#x2013;861.</Citation><ArticleIdList><ArticleId IdType="pubmed">9660968</ArticleId></ArticleIdList></Reference><Reference><Citation>Aragao D., Aishima J., Cherukuvada H., Clarken R., Clift M., Cowieson N.P., Ericsson D.J., Gee C.L., Macedo S., Mudie N. et al. .. MX2: a high-flux undulator microfocus beamline serving both the chemical and macromolecular crystallography communities at the Australian Synchrotron. J. Synchrotron Radiat. 2018; 25:885&#x2013;891.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5929359</ArticleId><ArticleId IdType="pubmed">29714201</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabsch W. Xds. Acta Crystallogr. 2010; 66:125&#x2013;132.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2815665</ArticleId><ArticleId IdType="pubmed">20124692</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans P.R., Murshudov G.N.. How good are my data and what is the resolution. Acta Crystallogr. 2013; 69:1204&#x2013;1214.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3689523</ArticleId><ArticleId IdType="pubmed">23793146</ArticleId></ArticleIdList></Reference><Reference><Citation>McCoy A.J., Grosse-Kunstleve R.W., Adams P.D., Winn M.D., Storoni L.C., Read R.J.. Phaser crystallographic software. J. Appl. Crystallogr. 2007; 40:658&#x2013;674.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2483472</ArticleId><ArticleId IdType="pubmed">19461840</ArticleId></ArticleIdList></Reference><Reference><Citation>Winn M.D., Ballard C.C., Cowtan K.D., Dodson E.J., Emsley P., Evans P.R., Keegan R.M., Krissinel E.B., Leslie A.G., McCoy A. et al. .. Overview of the CCP4 suite and current developments. Acta Crystallogr. 2011; 67:235&#x2013;242.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3069738</ArticleId><ArticleId IdType="pubmed">21460441</ArticleId></ArticleIdList></Reference><Reference><Citation>Emsley P., Lohkamp B., Scott W.G., Cowtan K.. Features and development of Coot. Acta Crystallogr. 2010; 66:486&#x2013;501.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2852313</ArticleId><ArticleId IdType="pubmed">20383002</ArticleId></ArticleIdList></Reference><Reference><Citation>Bricogne G., E. Blanc., Brandl M., Flensburg C., Keller P., Paciorek W., Roversi P., Sharff A., Smart O.S., Vonrhein C., Womack T.O.. 2017; BUSTER version 2.10.3. Cambridge, United Kingdom: Global Phasing Ltd.</Citation></Reference><Reference><Citation>Chen V.B., Arendall W.B. 3rd, Headd J.J., Keedy D.A., Immormino R.M., Kapral G.J., Murray L.W., Richardson J.S., Richardson D.C.. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. 2010; 66:12&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2803126</ArticleId><ArticleId IdType="pubmed">20057044</ArticleId></ArticleIdList></Reference><Reference><Citation>Bajaj M., Mamidyala S.K., Zuegg J., Begg S.L., Ween M.P., Luo Z., Huang J.X., McEwan A.G., Kobe B., Paton J.C. et al. .. Discovery of novel pneumococcal surface antigen A (PsaA) inhibitors using a fragment-based drug design approach. ACS Chem. Biol. 2015; 10:1511&#x2013;1520.</Citation><ArticleIdList><ArticleId IdType="pubmed">25786639</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirby N.M., Mudie S.T., Hawley A.M., Cookson D.J., Mertens H.D.T., Cowieson N., Samardzic-Boban V.. A low-background-intensity focusing small-angle X-ray scattering undulator beamline. J. Appl. Crystallogr. 2013; 46:1670&#x2013;1680.</Citation></Reference><Reference><Citation>Whitten A.E., Cai S.Z., Trewhella J.. MULCh: modules for the analysis of small-angle neutron contrast variation data from biomolecular assemblies. J. Appl. Crystallogr. 2008; 41:222&#x2013;226.</Citation></Reference><Reference><Citation>Konarev P.V., Volkov V.V., Sokolova A.V., Koch M.H.J., Svergun D.I.. PRIMUS: a Windows PC-based system for small-angle scattering data analysis. J. Appl. Crystallogr. 2003; 36:1277&#x2013;1282.</Citation></Reference><Reference><Citation>Svergun D.I. Determination of the regularization parameter in indirect-transform methods using perceptual criteria. J. Appl. Crystallogr. 1992; 25:495&#x2013;503.</Citation></Reference><Reference><Citation>Svergun D., Barberato C., Koch M.H.J.. CRYSOL - a program to evaluate x-ray solution scattering of biological macromolecules from atomic coordinates. J. Appl. Crystallogr. 1995; 28:768&#x2013;773.</Citation></Reference><Reference><Citation>Widagdo J., Chai Y.J., Ridder M.C., Chau Y.Q., Johnson R.C., Sah P., Huganir R.L., Anggono V.. Activity-dependent ubiquitination of GluA1 and GluA2 regulates AMPA receptor intracellular sorting and degradation. Cell Rep. 2015; 10:783&#x2013;795.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4524782</ArticleId><ArticleId IdType="pubmed">25660027</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan M.C., Widagdo J., Chau Y.Q., Zhu T., Wong J.J., Cheung A., Anggono V.. The activity-induced long non-coding RNA Meg3 modulates AMPA receptor surface expression in primary cortical neurons. Front. Cell Neurosci. 2017; 11:124.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5413565</ArticleId><ArticleId IdType="pubmed">28515681</ArticleId></ArticleIdList></Reference><Reference><Citation>Hewage T.W., Caria S., Lee M.. A new crystal structure and small-angle X-ray scattering analysis of the homodimer of human SFPQ. Acta Crystallogr. F Struct. Biol. Commun. 2019; 75:439&#x2013;449.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6572092</ArticleId><ArticleId IdType="pubmed">31204691</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang J., Casas&#xa0;Garcia G.P., Perugini M.A., Fox A.H., Bond C.S., Lee M.. Crystal structure of a SFPQ/PSPC1 heterodimer provides insights into preferential heterodimerization of human DBHS family proteins. J. Biol. Chem. 2018; 293:6593&#x2013;6602.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5925804</ArticleId><ArticleId IdType="pubmed">29530979</ArticleId></ArticleIdList></Reference><Reference><Citation>Religa D., Strozyk D., Cherny R.A., Volitakis I., Haroutunian V., Winblad B., Naslund J., Bush A.I.. Elevated cortical zinc in Alzheimer disease. Neurology. 2006; 67:69&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">16832080</ArticleId></ArticleIdList></Reference><Reference><Citation>Sensi S.L., Rapposelli I.G., Frazzini V., Mascetra N.. Altered oxidant-mediated intraneuronal zinc mobilization in a triple transgenic mouse model of Alzheimer's disease. Exp. Gerontol. 2008; 43:488&#x2013;492.</Citation><ArticleIdList><ArticleId IdType="pubmed">18068923</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang T.N., Lim N.K., Grubman A., Li Q.X., Volitakis I., White A.R., Crouch P.J.. Increased metal content in the TDP-43(A315T) transgenic mouse model of frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Front. Aging Neurosci. 2014; 6:15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3920072</ArticleId><ArticleId IdType="pubmed">24575040</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J., Kim T.Y., Hwang J.J., Lee J.Y., Shin J.H., Gwag B.J., Koh J.Y.. Accumulation of labile zinc in neurons and astrocytes in the spinal cords of G93A SOD-1 transgenic mice. Neurobiol. Dis. 2009; 34:221&#x2013;229.</Citation><ArticleIdList><ArticleId IdType="pubmed">19344646</ArticleId></ArticleIdList></Reference><Reference><Citation>Caragounis A., Price K.A., Soon C.P., Filiz G., Masters C.L., Li Q.X., Crouch P.J., White A.R.. Zinc induces depletion and aggregation of endogenous TDP-43. Free Radic. Biol. Med. 2010; 48:1152&#x2013;1161.</Citation><ArticleIdList><ArticleId IdType="pubmed">20138212</ArticleId></ArticleIdList></Reference><Reference><Citation>Frederickson C.J., Koh J.Y., Bush A.I.. The neurobiology of zinc in health and disease. Nat. Rev. Neurosci. 2005; 6:449&#x2013;462.</Citation><ArticleIdList><ArticleId IdType="pubmed">15891778</ArticleId></ArticleIdList></Reference><Reference><Citation>Watt N.T., Whitehouse I.J., Hooper N.M.. The role of zinc in Alzheimer's disease. Int. J. Alzheimers Dis. 2010; 2011:971021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3010690</ArticleId><ArticleId IdType="pubmed">21197404</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas-Jinu S., Gordon P.M., Fielding T., Taylor R., Smith B.N., Snowden V., Blanc E., Vance C., Topp S., Wong C.H. et al. .. Non-nuclear pool of splicing factor SFPQ regulates axonal transcripts required for normal motor development. Neuron. 2017; 94:322&#x2013;336.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5405110</ArticleId><ArticleId IdType="pubmed">28392072</ArticleId></ArticleIdList></Reference><Reference><Citation>Szewczyk B. Zinc homeostasis and neurodegenerative disorders. Front. Aging Neurosci. 2013; 5:33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3715721</ArticleId><ArticleId IdType="pubmed">23882214</ArticleId></ArticleIdList></Reference><Reference><Citation>McCord M.C., Aizenman E.. The role of intracellular zinc release in aging, oxidative stress, and Alzheimer's disease. Front. Aging Neurosci. 2014; 6:77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4028997</ArticleId><ArticleId IdType="pubmed">24860495</ArticleId></ArticleIdList></Reference><Reference><Citation>Leal S.S., Botelho H.M., Gomes C.M.. Metal ions as modulators of protein conformation and misfolding in neurodegeneration. Coordin. Chem. Rev. 2012; 256:2253&#x2013;2270.</Citation></Reference><Reference><Citation>Sirangelo I., Iannuzzi C.. The role of metal binding in the amyotrophic lateral sclerosis-related aggregation of copper-zinc superoxide dismutase. Molecules. 2017; 22:1429.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6151412</ArticleId><ArticleId IdType="pubmed">28850080</ArticleId></ArticleIdList></Reference><Reference><Citation>Garnier C., Devred F., Byrne D., Puppo R., Roman A.Y., Malesinski S., Golovin A.V., Lebrun R., Ninkina N.N., Tsvetkov P.O.. Zinc binding to RNA recognition motif of TDP-43 induces the formation of amyloid-like aggregates. Sci. Rep. 2017; 7:6812.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5533730</ArticleId><ArticleId IdType="pubmed">28754988</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobson L., Nyitray L., Gaspari Z.. A conserved charged single alpha-helix with a putative steric role in paraspeckle formation. RNA. 2015; 21:2023&#x2013;2029.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4647456</ArticleId><ArticleId IdType="pubmed">26428695</ArticleId></ArticleIdList></Reference><Reference><Citation>Afroz T., Hock E.M., Ernst P., Foglieni C., Jambeau M., Gilhespy L.A.B., Laferriere F., Maniecka Z., Pluckthun A., Mittl P. et al. .. Functional and dynamic polymerization of the ALS-linked protein TDP-43 antagonizes its pathologic aggregation. Nat. Commun. 2017; 8:45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5491494</ArticleId><ArticleId IdType="pubmed">28663553</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishigaki S., Fujioka Y., Okada Y., Riku Y., Udagawa T., Honda D., Yokoi S., Endo K., Ikenaka K., Takagi S. et al. .. Altered tau isoform ratio caused by loss of FUS and SFPQ function leads to FTLD-like phenotypes. Cell Rep. 2017; 18:1118&#x2013;1131.</Citation><ArticleIdList><ArticleId IdType="pubmed">28147269</ArticleId></ArticleIdList></Reference><Reference><Citation>Hergesheimer R.C., Chami A.A., de&#xa0;Assis D.R., Vourc&#x2019;h P., Andres C.R., Corcia P., Lanznaster D., Blasco H.. The debated toxic role of aggregated TDP-43 in amyotrophic lateral sclerosis: a resolution in sight. Brain. 2019; 142:1176&#x2013;1194.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6487324</ArticleId><ArticleId IdType="pubmed">30938443</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>